Skip to content
Search

Latest Stories

GPhC tightens rules for online obesity drug prescriptions

Obesity drug
Boxes of Wegovy are seen at a pharmacy in London. (Photo: Reuters)
Eastern Eye
By Eastern EyeFeb 04, 2025
Eastern Eye

See Full Bio

The General Pharmaceutical Council (GPhC), which oversees UK pharmacies, has introduced stricter rules for online pharmacies prescribing obesity drugs. The regulator said the changes aim to prevent individuals from receiving medicines that could pose health risks.

The new guidance, updated for the first time in three years, follows concerns about how some online pharmacies dispense weight-loss drugs.

The GPhC has also added GLP-1 receptor agonists, including weight-loss injections Wegovy and Mounjaro, to its list of "high-risk medicines."

These drugs will now require extra safeguards when prescribed, similar to opioids, sedatives, antibiotics, and medicines for long-term conditions like asthma and diabetes.

Demand for obesity drugs in the UK has grown significantly. Last year, several online pharmacies estimated that around 500,000 people were using these medications through the private market, surpassing the number receiving them via the state-run National Health Service (NHS).

"We have seen, through our inspections and concerns raised by the public, some concerning ways in which these drugs were being supplied online and we have taken action as a result," said Louise Edwards, Chief Strategy Officer at the GPhC.

Since 2021, the regulator has taken enforcement action against at least a dozen online pharmacies over their supply of weight-loss medicines, Edwards said.

Under the updated rules, online pharmacies must now "independently verify the person's weight, height, and/or body mass index" before prescribing obesity drugs.

This can be done through a video consultation, reviewing clinical records, or contacting the person's doctor. Online questionnaires and phone calls will no longer be considered sufficient for verification.

Wegovy is produced by Danish pharmaceutical company Novo Nordisk, while Mounjaro is made by US-based Lilly. Both companies have seen significant profits from their weight-loss drugs.

In December, the World Health Organization said these medications, alongside other health measures, could play a role in addressing the global obesity crisis.

diabetesgeneral pharmaceutical councilgphcmounjaroobesity drug prescriptionsobesity drugsonline pharmaciesuk pharmacieswegovyweightloss drugsozempic uk

Related News

London Tech Week
Business

London Tech Week: Woman entrepreneur says she was humiliated after being denied entry for bringing baby

Eid-prayer-Getty
Asia

Ahmadis stopped from offering Eid prayers in Pakistan

top indie films 2025
Entertainment

Top 10 indie films catching global attention before TIFF 2025

Arjun Rampal Rana Naidu
Entertainment

Arjun Rampal says Rauf in 'Rana Naidu' is the most ruthless role of his career

More For You

Bryan Johnson

Known for creating the “Don’t Die” project, Johnson has turned his body into a human laboratory

Getty Images

No pizza, no alcohol, no late nights: Bryan Johnson’s strict routine to defy ageing

Bryan Johnson, a 47-year-old tech entrepreneur from California, has become a prominent figure in the global longevity movement, attracting both fascination and criticism for his intense health regime. Known for creating the “Don’t Die” project, Johnson has turned his body into a human laboratory, experimenting with extreme methods to delay ageing and boost long-term health.

From tech success to health obsession

Johnson made headlines in 2013 after selling his company, Braintree, to PayPal for $800 million. Following years of depression and personal upheaval, including leaving the Church of Jesus Christ of Latter-day Saints and divorcing his wife, Johnson redirected his focus to health and longevity.

Keep ReadingShow less
What Makes the 'Nimbus' Covid Variant Symptoms Different?

Experts warn that nimbus may be more efficient at infecting human cells than earlier variants

iStock

Doctors warn of new covid symptom as nimbus variant spreads across the UK

A new covid variant, known as nimbus (scientifically NB.1.8.1), is causing concern among health experts as cases rise globally. The variant, a descendant of omicron, has been detected in several countries, including China, Singapore, Hong Kong, and the UK. While its symptoms are largely similar to previous covid strains, doctors have identified a distinctive new symptom: a razor blade sore throat, characterised by an intense stabbing pain when swallowing.

Experts warn that nimbus may be more efficient at infecting human cells than earlier variants, which could lead to increased transmission rates. Although there is no current evidence to suggest that it causes more severe illness than its predecessors, the rapid spread has raised concerns, particularly among vulnerable groups.

Keep ReadingShow less
Sands Extends Special Father’s Day Support to Bereaved Fathers

The charity is encouraging individuals to honour a bereaved father with a special online dedication

iStock

This Father’s Day, Sands charity offers vital support to bereaved fathers

As Father’s Day approaches, the UK’s leading pregnancy and baby loss charity, Sands, is extending vital support to grieving fathers and their families. With Sunday, 15 June, likely to be a challenging day for many, the charity is making special efforts to ensure bereaved dads do not feel alone.

Sands has announced extended hours for its confidential Freephone Helpline (0808 164 3332), which will be open from 10 am to 12 pm on Father’s Day. This service offers a safe, non-judgmental space for those affected by pregnancy or baby loss to talk and seek support. Support is also available via email (helpline@sands.org.uk) and through the charity’s online community atwww.sands.community.

Keep ReadingShow less
NHS Issues Emergency Appeal for 200,000 Blood Donors as Supplies Dwindle

NHS Blood and Transplant (NHSBT) is aiming to boost the number of active donors to one million to meet growing demand

iStock

NHS appeals for 200,000 more donors as blood stocks fall dangerously low

The NHS has launched an urgent appeal for more people to come forward for blood donation, warning that a shortage of over 200,000 donors in England could pose a risk to public safety. NHS Blood and Transplant (NHSBT) is aiming to boost the number of active donors to one million to meet growing demand.

Blood supplies under pressure

Currently, fewer than 800,000 people – just 2% of England’s population – give blood regularly. This small group kept the NHS running last year, but officials say more support is needed. A severe drop in supply last year led to an amber alert, and NHSBT warns that without more blood donations, the situation could escalate to a red alert, meaning hospitals may not have enough blood for patients in critical need.

Keep ReadingShow less
Romesh Ranganathan

Ranganathan discussed experiencing suicidal thoughts in the past and the steps he has taken to improve his mental health

BBC Radio 4

Romesh Ranganathan speaks candidly about mental health and family struggles

Comedian and presenter Romesh Ranganathan has opened up about his long-term mental health challenges, describing how he has found effective ways to manage his wellbeing and now feels he is in “one of the best places I’ve ever been in my life”.

Speaking on BBC Radio 4’s Desert Island Discs, Ranganathan discussed experiencing suicidal thoughts in the past and the steps he has taken to improve his mental health. He also reflected on his Sri Lankan heritage, his upbringing, and the difficulties his family faced during his youth.

Keep ReadingShow less
© Copyright 2025 Garavi Gujarat Publications Ltd & Asian Media Group USA Inc